StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
16
Publishing Date
2022 - 01 - 21
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 12 - 12
1
2021 - 12 - 09
1
2021 - 11 - 13
1
2021 - 11 - 05
1
2021 - 10 - 04
1
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 05 - 15
1
2021 - 05 - 03
1
2021 - 04 - 19
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 03 - 31
1
Sector
Health technology
16
Tags
Genetic
1
Givlaari
1
Kidney
2
N/a
16
Oxlumo
1
Phase 1
2
Phase 2
2
Phase 3
8
Presentation
1
Results
16
Tcom
1
Entities
Alnylam pharmaceuticals, inc.
16
Sanofi
1
Symbols
ALNY
16
SNY
1
SNYNF
1
Exchanges
Nasdaq
16
Crawled Date
2022 - 01 - 21
1
2021 - 12 - 14
2
2021 - 12 - 12
1
2021 - 12 - 09
1
2021 - 11 - 13
1
2021 - 11 - 05
1
2021 - 10 - 04
1
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 05 - 15
1
2021 - 05 - 03
1
2021 - 04 - 19
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 03 - 31
1
Crawled Time
00:00
1
03:00
1
04:20
1
12:00
1
13:00
2
14:00
1
15:30
1
16:20
2
18:00
2
19:00
1
20:20
2
22:00
1
Source
apyxmedical.com
27
firstcobalt.com
19
hightideinc.com
18
investor.alkermes.com
17
investor.assemblybio.com
11
investor.aveooncology.com
15
investors.biomarin.com
15
ir.akerotx.com
11
ir.arberobotics.com
14
ir.ateapharma.com
12
ir.auriniapharma.com
20
ir.biolinerx.com
16
ir.check-cap.com
11
ir.cleverleaves.com
13
ir.iqvia.com
26
ir.kalvista.com
12
ir.servicesource.com
15
ir.sypris.com
17
ir.therapeuticsmd.com
15
ir.viveve.com
20
jaguarhealth.gcs-web.com
12
neurosense.investorroom.com
11
ocutx.gcs-web.com
15
spacfeed.com
398
velodynelidar.com
17
www.4frontventures.com
11
www.admabiologics.com
17
www.adnas.com
16
www.alnylam.com
16
www.ameresco.com
21
www.arcadiabio.com
21
www.archcapgroup.com
23
www.balchem.com
22
www.bbxcapital.com
17
www.biospace.com
7308
www.blackknightinc.com
16
www.bry.com
15
www.burcon.ca
12
www.caledoniamining.com
13
www.ceragon.com
17
www.cvdequipment.com
16
www.farmermac.com
20
www.globalp.com
17
www.globenewswire.com
23558
www.igcinc.us
11
www.kopin.com
15
www.kosmosenergy.com
15
www.lomiko.com
12
www.nanthealth.com
15
www.nexstar.tv
12
www.ooma.com
18
www.prnewswire.com
11505
www.repay.com
21
www.safebulkers.com
12
www.stagindustrial.com
17
www.sunopta.com
19
www.teekay.com
17
www.thermogenesis.com
12
www.universallogistics.com
12
www.versabank.com
14
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
source :
Www.alnylam.com
save search
18-Month Results from HELIOS-A Phase 3 Study of Vutrisiran Presented at SFNP
Published:
2022-01-21
(Crawled : 13:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
0.03%
|
O:
-10.41%
H:
0.0%
C:
0.0%
results
phase 3
New Results from Phase 1 Study of Cemdisiran + Pozelimab Presented at ASH Annual Meeting 2021
Published:
2021-12-14
(Crawled : 03:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-16.86%
|
O:
6.02%
H:
2.03%
C:
-0.29%
phase 1
results
phase 2
phase 3
New Long-Term Results for GIVLAARI® (givosiran) Presented at ASH Annual Meeting & Exposition
Published:
2021-12-13
(Crawled : 00:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-16.86%
|
O:
6.02%
H:
2.03%
C:
-0.29%
givlaari
results
New Results from ATLAS Phase 3 Program with Fitusiran Presented at ASH Annual Meeting 2021
Published:
2021-12-12
(Crawled : 20:20)
- alnylam.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-2.92%
|
O:
3.01%
H:
0.28%
C:
-2.39%
SNY
|
News
|
$47.1
-1.24%
260K
|
Health Technology
|
-3.58%
|
O:
-0.42%
H:
0.0%
C:
0.0%
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-14.54%
|
O:
2.8%
H:
0.0%
C:
0.0%
results
phase 3
ILLUMINATE-B Phase 3 Results of OXLUMO® (lumasiran) Published in Genetics in Medicine
Published:
2021-12-09
(Crawled : 15:30)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-17.44%
|
O:
0.29%
H:
0.31%
C:
-2.8%
oxlumo
genetic
results
phase 3
New Results for Zilebesiran Presented at AHA Scientific Sessions 2021
Published:
2021-11-13
(Crawled : 16:20)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
Email alert
Add to watchlist
results
Results from ILLUMINATE-C Phase 3 Study of Lumasiran Presented at ASN Kidney Week 2021
Published:
2021-11-05
(Crawled : 18:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-21.28%
|
O:
-0.02%
H:
0.0%
C:
0.0%
results
phase 3
kidney
New Long-Term Results for GIVLAARI® (givosiran) Presented at UEG Week Virtual 2021
Published:
2021-10-04
(Crawled : 13:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-22.59%
|
O:
3.34%
H:
1.56%
C:
0.01%
results
New Results from the OXLUMO® (lumasiran) Clinical Program Presented at AUA Annual Meeting
Published:
2021-09-10
(Crawled : 18:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-22.96%
|
O:
0.43%
H:
1.06%
C:
-0.46%
results
New Results for Vutrisiran at EU-ATTR Amyloidosis Meeting
Published:
2021-09-07
(Crawled : 14:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
-26.79%
|
O:
-0.93%
H:
0.0%
C:
-4.76%
results
Complete Results from Phase 1/2 Study of Lumasiran (OXLUMO®) Published in Clinical Journal of the American Society of Nephrology
Published:
2021-05-15
(Crawled : 04:20)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
Email alert
Add to watchlist
phase 1
results
phase 3
phase 2
Early Results on Clinical Outcome Measures Presented for OXLUMO® (lumasiran) at ASPN/PAS 2021 Annual Congress
Published:
2021-05-03
(Crawled : 12:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
3.86%
|
O:
-0.11%
H:
0.09%
C:
-3.66%
tcom
results
HELIOS-A Phase 3 Results for Vutrisiran Presented at AAN
Published:
2021-04-19
(Crawled : 19:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
6.31%
|
O:
-4.11%
H:
3.92%
C:
3.25%
results
phase 3
presentation
New Results for ALN-AGT at the ESH-ISH 2021 Joint Meeting
Published:
2021-04-11
(Crawled : 16:20)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
Email alert
Add to watchlist
results
New Analyses of OXLUMO® (lumasiran) ILLUMINATE-A Results at the National Kidney Foundation Virtual Spring Clinical Meetings
Published:
2021-04-10
(Crawled : 20:20)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
Email alert
Add to watchlist
results
kidney
ILLUMINATE-A Phase 3 Results for Lumasiran Published in The New England Journal of Medicine
Published:
2021-03-31
(Crawled : 22:00)
- alnylam.com
ALNY
|
$144.65
-0.97%
90K
|
Health Technology
|
3.46%
|
O:
1.4%
H:
1.39%
C:
-0.95%
results
phase 3
Gainers vs Losers
66%
34%
Top 10 Gainers
CZOO
|
$11.44
129.26%
4.6M
|
AMST
|
$3.4
70.0%
51M
|
Technology Services
BOF
|
$1.78
52.14%
15M
|
CSSE
4
|
$0.23
51.02%
46M
|
Consumer Services
TROO
|
$1.57
44.04%
2.8M
|
Manufacturing
RILY
|
$30.87
42.13%
7.8M
|
Finance
LICN
|
$0.76
35.71%
6.2M
|
MULN
|
News
|
$3.53
29.3%
4.8M
|
Information
RBBN
4
|
$3.26
26.85%
1.2M
|
Electronic Technology
RCAT
|
$1.52
26.67%
1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.